December 9, 2023

Hbs Ag

HEV ORF2 and ORF3 Ag Protein
abx060578-1mg 1 mg
EUR 1830

Hbsag Assay Laboratories manufactures the hbs ag reagents distributed by Genprice. The Hbs Ag reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact hbsag assay. Other Hbs products are available in stock. Specificity: Hbs Category: Ag

True north Cryobox 50mLBlue
PK10
EUR 210

True north Cryobox1.5/2mLNatural
PK10
EUR 162

True north Cryobox1.5/2.0mLGreen
PK10
EUR 162

True north Cryobox 1.5/2.0mLBlue
PK10
EUR 100.8

True north Cryobox 1.5/2.0mLBlue
PK10
EUR 162

True north Cryobox 1.5/2mLPurple
PK10
EUR 162

Dog True insulin ELISA kit
192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Canine True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Biology information

AG 1478
1800-5 each
EUR 210

AG-14361
27602-1 5 mg
EUR 205
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks.

AG-14361
27602-2 10 mg
EUR 360
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks.

AG-14361
27602-3 50 mg
EUR 825
Description: AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides. AG14361 treatment before irradiation statistically significantly increases the sensitivity to radiation therapy. AG14361 enhances the growth-inhibitory and cytotoxic effects of topoisomerase I poisons and increases the persistence of camptothecin-induced DNA single-strand breaks.

AG-126
C4338-10 10 mg
EUR 289.2
Description: IC50: inhibits the phosphorylation of ERK1 and ERK2 at 25-50 ?MAG-126 is an ERK1 and ERK2 inhibitor.

AG-126
C4338-25 25 mg
EUR 582
Description: IC50: inhibits the phosphorylation of ERK1 and ERK2 at 25-50 ?MAG-126 is an ERK1 and ERK2 inhibitor.

AG-126
C4338-5 5 mg
EUR 184.8
Description: IC50: inhibits the phosphorylation of ERK1 and ERK2 at 25-50 ?MAG-126 is an ERK1 and ERK2 inhibitor.

AG-1557
C5417-10 10 mg
EUR 247.2
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases.

AG-1557
C5417-25 25 mg
EUR 502.8
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases.

AG-1557
C5417-5 5 mg
EUR 158.4
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases.

AG-1557
C5417-50 50 mg
EUR 847.2
Description: pIC50: 8.194AG-1557 is an inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase.The epidermal growth factor receptor (EGFR) is a member of the receptor family of tyrosine kinases.

AG-1295
C5465-10 10 mg
EUR 309.6
Description: IC50: 0.3-1 ?M for PDGF receptor kinase in vitro and in Swiss 3T3 cells AG-1295 is a potent and selective inhibitor of PDGF receptor kinase. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs.

AG-1295
C5465-25 25 mg
EUR 582
Description: IC50: 0.3-1 ?M for PDGF receptor kinase in vitro and in Swiss 3T3 cells AG-1295 is a potent and selective inhibitor of PDGF receptor kinase. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs.

AG-1295
C5465-5 5 mg
EUR 195.6
Description: IC50: 0.3-1 ?M for PDGF receptor kinase in vitro and in Swiss 3T3 cells AG-1295 is a potent and selective inhibitor of PDGF receptor kinase. Protein tyrosine kinase (PTK) inhibitors are potential antiproliferative agents for diseases caused by the hyperactivity of PTKs.

AG-041R
C4101-10 10 mg
EUR 540
Description: AG-041R is a cholecystokinin-B/gastrin receptor (Gastrin/CCK-B) antagonist [1]. The Gastrin/CCK-B receptor is a regulator of gastric acid secretion and mucosal growth.

AG-041R
C4101-5 5 mg
EUR 331.2
Description: AG-041R is a cholecystokinin-B/gastrin receptor (Gastrin/CCK-B) antagonist [1]. The Gastrin/CCK-B receptor is a regulator of gastric acid secretion and mucosal growth.

AG-041R
C4101-50 50 mg
EUR 2164.8
Description: AG-041R is a cholecystokinin-B/gastrin receptor (Gastrin/CCK-B) antagonist [1]. The Gastrin/CCK-B receptor is a regulator of gastric acid secretion and mucosal growth.